Welcome Visitor Thursday, April 25, 2024

Articles related to Amgen


Vanderbilt IP licensed to IPO-prospect Neumora might earn VU millions
Vanderbilt IP licensed to IPO-prospect Neumora might earn VU millions

Scenario: VU could garner up to $422MM, as fight against neurospsych disorders, degenerative diseases advances.

Read More
Recruiters target Nashville's life-sciences sector
Recruiters target Nashville's life-sciences sector

[updated] Though their faith in the future may vary, retained executive-search professionals are investing energy in Bio and related fields.

Read More

Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: